Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Technology appraisal guidance
Reference number: TA261
Published: 25 July 2012

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: comments on the ACD from the public through the NICE website

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: comments on the ACD from the public through the NICE website

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: comments on the ACD from the public through the NICE website
01 June 2012
(37.47 Kb 10 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 28 May 2012